Search

1. Bempedoic acid and inclisiran for patients with heterozygous familial hypercholesterolemia and for secondary prevention of ASCVD: Effectiveness and value : final report

Author(s):

Lin, Grace A., author
Jih, Jane, author
Agboola, Foluso, author
Peason, Steven D., author
Kazi, Dhruv S., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 2, 2021

Subject(s):

Anticholesteremic Agents -- therapeutic use
Atherosclerosis -- prevention & control
ATP Citrate (pro-S)-Lyase -- antagonists & inhibitors
Dicarboxylic Acids -- therapeutic use
Fatty Acids
Hyperlipoproteinemia Type II -- drug therapy
RNA, Small Interfering
Secondary Prevention
Treatment Outcome
Drug Therapy, Combination
Ezetimibe -- therapeutic use
United States

2. We're holding the presses

Publication:

[Bethesda, Md. : National Heart, Lung, and Blood Institute, 197-?]

Subject(s):

Coronary Disease -- prevention & control
Famous Persons
Anticholesteremic Agents -- therapeutic use
Research Subjects
Coronary Primary Prevention Trial.

3. The ball's in your court

Publication:

[Bethesda, Md. : National Heart, Lung, and Blood Institute, 197-?]

Subject(s):

Coronary Disease -- prevention & control
Famous Persons
Black or African American
Anticholesteremic Agents -- therapeutic use
Research Subjects
Coronary Primary Prevention Trial.

4. The medical world salutes you

Publication:

[Bethesda, Md. : National Heart, Lung, and Blood Institute, 197-?]

Subject(s):

Coronary Disease -- prevention & control
Famous Persons
Anticholesteremic Agents -- therapeutic use
Research Subjects
Coronary Primary Prevention Trial.

5. PCSK9 inhibitors for treatment of high cholesterol: effectiveness, value, and value-based price benchmarks : final report

Author(s):

Tice, Jeffrey A., author
Ollendorf, Daniel A., author
Cunningham, Courtney, author
Pearson, Steven D., author
Kazi, Dhruv S., author
Coxson, Pamela G., author
Moran, Andrew E., author
Penko, Joanne, author
Guzman, David, author
Bibbins, Kirsten, author

Publication:

[Boston, MA] : Institute for Clinical and Economic Review, November 24, 2015

Subject(s):

Anticholesteremic Agents -- therapeutic use
Azetidines -- therapeutic use
Enzyme Inhibitors -- therapeutic use
Hypercholesterolemia -- therapy
Hyperlipoproteinemia Type II -- prevention & control
Proprotein Convertases -- economics
Serine Endopeptidases -- economics
New England
United States